GABA administration limits viral replication and pneumonitis in a mouse model of COVID-19
J. Tian, B. Middleton, D. L. Kaufman
This study shows that GABA treatment reduces viral load and lung inflammation in a mouse model of COVID-19, suggesting GABA-Rs as a potential therapeutic target.
bioRxiv · Feb 9, 2021 · PreprintImmunology